Altamira Therapeutics Stock (NASDAQ: CYTO) stock price, news, charts, stock research, profile.
Open | $1.540 |
Close | $1.690 |
Volume / Avg. | 166.204K / 1.174M |
Day Range | 1.495 - 1.770 |
52 Wk Range | 1.350 - 28.400 |
Market Cap | $3.764M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 48 |
Short Interest | 20.02% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Altamira Therapeutics (NASDAQ: CYTO) through any online brokerage.
Other companies in Altamira Therapeutics’s space includes: Cingulate (NASDAQ:CING), NovaBay Pharmaceuticals (AMEX:NBY), cbdMD (AMEX:YCBD), 60 Degrees (NASDAQ:SXTP) and MyMD Pharmaceuticals (NASDAQ:MYMD).
There is no analysis for Altamira Therapeutics.
The stock price for Altamira Therapeutics (NASDAQ: CYTO) is $1.68 last updated Today at April 26, 2024 at 5:14 PM EDT.
There are no upcoming dividends for Altamira Therapeutics.
Altamira Therapeutics’s FY earnings are confirmed for Wednesday, April 10, 2024.
There is no upcoming split for Altamira Therapeutics.
Altamira Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.